Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000365132

Medchemexpress LLC Y-320 | 288250-47-5 | 99.0% | 505.01 | 10 MG
SDP

Catalog No. 5000365132
Encompass_Preferred

Y-320 is a potent, orally active phenylpyrazoleanilide immunomodulator. It inhibits IL-17 production by CD4 T cells stimulated with IL-15 and enhances TP53, DMD, and COL17A1 PTC readthrough by G418. This compound significantly sensitizes multidrug resistance tumors by inducing G2/M phase arrest and apoptosis when used with low-dose Paclitaxel, making it suitable for research on rheumatoid arthritis and cancer.

  • Potent, orally active immunomodulator
  • Inhibits IL-17 production by CD4 T cells
  • Enhances PTC readthrough for TP53, DMD, and COL17A1
  • Increases cellular protein levels and synthesis
  • Sensitizes multidrug resistance (MDR) tumors
  • Induces G2/M phase arrest and apoptosis
  • Ameliorates collagen-induced arthritis (CIA)
  • Used in research for rheumatoid arthritis and cancer

Catalog No. 50-003-65132 Supplier Medchemexpress LLC Supplier No. 10MGHY15898
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Y-320 is a potent, orally active phenylpyrazoleanilide immunomodulator. It inhibits IL-17 production by CD4 T cells stimulated with IL-15 and enhances TP53, DMD, and COL17A1 PTC readthrough by G418. This compound significantly sensitizes multidrug resistance tumors by inducing G2/M phase arrest and apoptosis when used with low-dose Paclitaxel, making it suitable for research on rheumatoid arthritis and cancer.

  • Potent, orally active immunomodulator
  • Inhibits IL-17 production by CD4 T cells
  • Enhances PTC readthrough for TP53, DMD, and COL17A1
  • Increases cellular protein levels and synthesis
  • Sensitizes multidrug resistance (MDR) tumors
  • Induces G2/M phase arrest and apoptosis
  • Ameliorates collagen-induced arthritis (CIA)
  • Used in research for rheumatoid arthritis and cancer

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.